This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

"Global Appeal 2013" Calls For Immediate Repeal Of Laws And Institutions Discriminatory Against Leprosy-affected People

TOKYO, Jan. 25, 2013 /PRNewswire/ -- The Nippon Foundation held a launch ceremony in London on January 24 for the "Global Appeal 2013" designed end stigma and discrimination against people affected by leprosy, calling for the immediate abolition of laws and systems still discriminating against patients and recovered patients despite the fact that Hansen's disease has became curable.


The Nippon Foundation Chairman Yohei Sasakawa, acting as WHO Goodwill Ambassador for Leprosy Elimination, has been making the appeal annually since 2006 with the endorsement of religious, educational and human rights organizations around the world, with the eighth appeal in 2013 supported by the International Bar Association (IBA) and 46 affiliated bar associations in 40 countries and one region.

Nearly 200 people, including members of the bar and a representative of an Indian organization of recovered patients, were present at the ceremony held on the afternoon of January 24 in London. Lucy Scott-Moncrieff, president of the Law Society, told the audience: "It is truly significant that lawyers are taking a major role in the fight against the discrimination and injustice in this area." Former IBA President Akira Kawamura added, "The outdated attitudes and laws surrounding leprosy cause great suffering to many people. Today the members of legal professions across the world have an opportunity to work together to correct the situation." The Nippon Foundation's Sasakawa said, "Wrong laws and rules have helped encourage discrimination and stigma deeply planted in the minds of people," calling for their immediate repeal.

Over 16 million people affected by Hansen's disease have been cured over the world after the development of treatment drugs in the 1980s. But they are still faced today with misunderstanding and prejudice formed in the long history of the disease and are seriously discriminated against in marriage, employment and education. In India and some other countries, laws and institutions, which discriminate against patients and recovered patients, still remain unchanged.

Contact: Natsuko Tominaga/ Makoto WadaPublic Relations DepartmentThe Nippon FoundationTel: +81-3-6229-5131E-mail:

SOURCE The Nippon Foundation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.21 -0.44%
FB $117.80 -0.22%
GOOG $701.26 0.80%
TSLA $211.34 -5.00%
YHOO $36.94 2.60%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs